New stents tested in thousands of heart patients
NCT ID NCT05044273
First seen Jan 09, 2026 · Last updated Jun 22, 2026 · Updated 21 times
Summary
This study is tracking 2,000 people with coronary artery disease who receive either a Synergy XD or Synergy Megatron stent during a routine procedure to open blocked heart arteries. Researchers want to see how these stents perform in everyday medical practice compared to other drug-eluting stents. The main goal is to measure the rate of death, heart attack, or need for another procedure over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR DISEASES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Asan Medical Center
RECRUITINGSeoul, South Korea
Contact
Contact
-
CHA Bundang Medical Center, CHA University
TERMINATEDSeongnam, South Korea
-
Chonnam National University Hospital
RECRUITINGGwangju, South Korea
Contact
Contact
-
Dong-A University Hospital
RECRUITINGBusan, South Korea
Contact
Contact
-
Gangneung Asan Hospital
RECRUITINGGangneung, South Korea
Contact
Contact
-
Gyeongsang National University Changwon Hospital
RECRUITINGChangwon, South Korea
Contact
Contact
-
Hallym University Medical Center
RECRUITINGAnyang, South Korea
Contact
Contact
-
Hanyang University Seoul Hospital
RECRUITINGSeoul, South Korea
Contact
Contact
-
Inje University Busan Paik Hospital
TERMINATEDBusan, South Korea
-
Inje university Pusan Paik hospital
RECRUITINGBusan, South Korea
Contact
Contact
-
Keimyung University Dongsan Medical Center
RECRUITINGDaegu, South Korea
Contact
Contact
-
Korea University Anam Hospital
RECRUITINGSeoul, South Korea
Contact
Contact
-
Korea University Guro Hospital
TERMINATEDSeoul, South Korea
-
Pusan National University Hospital
TERMINATEDBusan, South Korea
-
Pusan National University Hospital
RECRUITINGBusan, South Korea
Contact
Contact
-
Pusan National University Yangsan Hospital
RECRUITINGBusan, South Korea
Contact
Contact
-
Samsung Changwon Hospital
RECRUITINGChangwon, South Korea
Contact
Contact
-
Seoul university Bundang hospital
RECRUITINGSeongnam, South Korea
Contact Email: •••••@•••••
Contact
-
The Catholic University of Korea, ST. Vincent's Hospital
RECRUITINGSuwon, South Korea
Contact
Contact
-
Ulsan University Hospital
RECRUITINGUlsan, South Korea
Contact
Contact
-
Veterans Hospital
RECRUITINGDaegu, South Korea
Contact
Contact
-
Wonkwang University Hospital
RECRUITINGIksan, South Korea
Contact
Contact
-
Yeungnam University Medical Center
RECRUITINGDaegu, South Korea
Contact
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Synergy XD stent and Synergy Megatron stent (drug-eluting stents)
What this could lead to
If successful, this could show that these stents are a safe and effective option for opening blocked heart arteries in everyday practice.
What could go wrong
This is an observational study, not a controlled trial, so results may be less definitive. Stents carry risks like blood clots or re-narrowing of the artery.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.